Patents
Patents for C07K 19 - Hybrid peptides (29,428)
08/2008
08/28/2008WO2008080218A9 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
08/28/2008US20080207485 Major histocompatibility complex with peptide binding grooves; controlling oligomerization
08/28/2008US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides
08/28/2008US20080206247 Glycoprotein VI fusion proteins
08/28/2008US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008DE102007010306A1 Bispezifisches Fusionsprotein mit therapeutischem und diagnostischem Potenzial The bispecific fusion protein with therapeutic and diagnostic potential
08/28/2008CA2678966A1 Chimeric newcastle disease virus vlps
08/27/2008EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer
08/27/2008EP1961813A2 Human cyclin-dependent kinase (hPNQALRE)
08/27/2008EP1961811A1 Novel cytokine ZCYTOR17 ligand
08/27/2008EP1961425A2 Methods and compositions for the prevention and treatment of anemia
08/27/2008EP1960427A1 Multimeric fc receptor polypeptides
08/27/2008EP1440156B1 Antigens and vectors for vaccination
08/27/2008EP1355942B1 Glp-1 fusion proteins
08/27/2008EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
08/27/2008EP1156817B1 Controlling protein levels in eucaryotic organisms
08/27/2008EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1
08/27/2008EP0826060B1 Embedded expression of heterologous proteins
08/27/2008CN101253264A 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ
08/27/2008CN100413969C Chimeric gene with delta 6 fatty acid dehydrogenase function and its use
08/27/2008CN100413885C Modified proteins, designer toxins and methosd of making thereof
08/26/2008US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein.
08/21/2008WO2008100112A1 Transgenic plants exhibiting increased resistance to biotic and abiotic stresses or accelerated flowering time and methods for producing the same
08/21/2008WO2008099968A1 Zinc oxide-binding antibody and use thereof
08/21/2008WO2008077406A3 Coupling of elements
08/21/2008WO2008035217A3 Fusion proteins comprising two or more igg binding domains of streptococcal protein g.
08/21/2008US20080200948 Novel biomaterials and a method for making and using same
08/21/2008US20080199934 Adding functional groups to peptides for use in preparation of muscle and silk protein
08/21/2008US20080199476 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
08/21/2008US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders
08/21/2008CA2677748A1 Binding members for ige molecules
08/21/2008CA2664791A1 Recombinant rhinovirus vectors
08/20/2008EP1958965A2 Agonist antibodies to a musk receptor, and their therapeutic uses
08/20/2008EP1958960A2 A process for the preparation of a non-toxic anthrax vaccine
08/20/2008EP1958959A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
08/20/2008EP1957541A2 Compositions and methods of producing hybrid antigen binding molecules and uses thereof
08/20/2008EP1523336B1 Targeted agents for nerve regeneration
08/20/2008EP1368050B1 Virus derived antimicrobial peptides
08/20/2008EP1356052B1 Production of full antibodies in procaryotic cells
08/20/2008EP1334123B1 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/20/2008EP1227829B1 Novel chimeric analgesic peptides
08/20/2008CN101245111A High-efficiency expression and renaturation of novel anticoagulation thrombolysis double-function protein
08/20/2008CN101245110A Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition
08/20/2008CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
08/19/2008US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping
08/14/2008WO2008095905A2 Pathogen binding
08/14/2008WO2008095677A1 Recombinant antigens of human cytomegalovirus (hcmv)
08/14/2008US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
08/14/2008DE102005028619A1 New Cherkasky fusion protein comprises antibody binding protein, non-antibody binding domain and/or any domain useful as materials, medicines, coloring- and labelling materials, adhesives and diagnostic systems
08/14/2008CA2715045A1 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
08/14/2008CA2677455A1 Recombinant antigens of human cytomegalovirus (hcmv)
08/14/2008CA2677160A1 Variants derived from actriib and uses therefor
08/13/2008EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same
08/13/2008EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby
08/13/2008EP1137773B1 Growth factor homolog zvegf3
08/13/2008EP1133519B1 Functional antagonists of hedgehog activity
08/13/2008CN101240033A Fusion protein of insulin secretion accelerating peptide and human serum albumin, and preparation method thereof
08/13/2008CN101240032A Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application
08/13/2008CN101239186A Use of soluble lymphotoxin-beta receptors
08/13/2008CN100410276C Polypeptide
08/12/2008US7411055 Genetic engineering
08/12/2008US7411041 DCRS5 polypeptides
08/12/2008US7410780 IL-21 antagonists
08/12/2008US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
08/12/2008US7410648 Nucleotide sequences coding outer memebrane proteins for use as tools in diagnosis, prevention and treatment of microorganismal infection; immunotherapy; vaccine development
08/12/2008US7410645 Moraxella (Branhamella) catarrhalis antigens
08/12/2008CA2330235C Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
08/12/2008CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof
08/07/2008WO2008093756A1 Biological preparation
08/07/2008WO2008093688A1 CHIMERIC Fcγ RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR
08/07/2008WO2008092209A1 Protein construct with improved properties
08/07/2008US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer
08/07/2008US20080187538 Posh nucleic acids, polypeptides and related methods
08/07/2008CA2674721A1 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
08/07/2008CA2659275A1 Chimeric influenza virus-like particles
08/07/2008CA2657955A1 Chimeric virus-like particles
08/06/2008EP1953229A2 Metastatic breast and colon cancer regulated genes
08/06/2008EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same
08/06/2008EP1951319A2 Chimeric immunoreceptor useful in treating human cancers
08/06/2008EP1585546B1 Kim-1 antagonists and use to modulate immune system
08/06/2008EP1478777B1 Genetic marker for diffentiating mycobacteria
08/06/2008EP1468284B1 Method for measuring intracellular atp and/or gene expression
08/06/2008EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
08/06/2008EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof
08/06/2008EP1108034B1 Attenuated salmonella spi2 mutants as antigen carriers
08/06/2008EP1042467B1 Non-identical genes and their application in improved molecular adjuvants
08/06/2008EP0941241B1 Bordetella strain expressing the fha hybrid,
08/06/2008CN101235090A Specificity fusion protein applied to tuberculosis rapid diagnosis
08/06/2008CN101234193A Stable water solution containing recombination human serum albumin fusion interferon
08/05/2008US7408033 PRO5995 polypeptides
08/05/2008US7407475 Modified annexin proteins, and methods and compositions for using them
08/05/2008CA2347960C A method of affinity separation and ligands for use therein
08/05/2008CA2306188C A novel method for the integration of foreign dna into eukaryotic genomes
07/2008
07/31/2008WO2008090174A1 New anti-malaria vaccine compositions and uses thereof
07/31/2008WO2008089645A1 Fusion polypeptide inhibiting cell growth and use thereof
07/31/2008WO2008089569A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
07/31/2008WO2008089567A1 Cancerous disease modifying antibodies
07/31/2008WO2008089566A1 Cancerous disease modifying antibodies